Indication

Uterine Endometrial Cancer

1 clinical trial

1 product

Clinical trial

A Pilot Study Investigating the Effect of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers of Mullerian Origin

Status: Completed, Estimated PCD: 2019-01-31

Product